Research, Science & Development
-
Oxford/CEPI Lassa vaccine enters clinical trial in Nigeria
Experts project that up to 700 million people could inhabit areas vulnerable to Lassa fever by 2070.
-
FDA issues draft guidance to reduce primate testing in monoclonal antibody development
Macaque monkeys serve as the most common species for drug testing because they share considerable physiological similarities with humans.
-
Cinfa – A comprehensive commitment to diabetes
Scientific Progress, Knowledge Exchange, and Continuous Dialogue
-
Half of heart attacks in younger women due to non-artery blockage causes, Mayo Clinic study reveals
The study found that over half of heart attacks in women under 65 were linked to nontraditional causes such as spontaneous coronary artery dissection (SCAD), embolism, and other conditions unrelated to artery plaque.
-
IMPALA Study finds two-monthly injectable HIV treatment safe and preferred by African patients
Results showed that the injectable regimen performed just as well as the daily oral dolutegravir-based therapy (TLD) but helped reduce the burden of daily medication.
-
African leaders to convene high-level health summit at ICASA 2025 in Ghana
The event will take place on December 3 at the Accra International Conference Centre, immediately following the opening ceremony of the International Conference on AIDS and STIs in Africa (ICASA 2025).